Moreover, the findings indicated that baicalin has the potential to reduce joint inflammation and tissue damage in a rat model of collagen-induced arthritis (CIA) by modulating the TLR2/MYD88/NF-κB p65 signaling pathway, thus offering a novel therapeutic approach for rheumatoid arthritis management (193). This evidence concerns the gene MYD88 and rheumatoid arthritis.